CollPlant Biotechnologies Ltd.
CLGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -95.3% | 3,565.2% | -98.1% | – |
| Gross Profit | -$0 | $0 | -$0 | $0 |
| % Margin | -417.1% | 71.8% | -393.6% | 87.2% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -3,020.2% | -53.9% | -5,289.3% | 6.7% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -3,225% | -64% | -5,660.5% | 1.5% |
| EPS Diluted | -1.45 | -0.62 | -1.52 | 0.034 |
| % Growth | -133.9% | 59.2% | -4,544.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |